tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Cash flow

320 Followers

ARS Pharmaceuticals Cash Flow

SPRY's free cash flow for Q2 2024 was $-7.32M. For the 2024 fiscal year, SPRY's free cash flow was decreased by $-19.16M and operating cash flow was $-7.28M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -44.16M$ -59.27M$ -40.08M$ -17.56M$ -31.20M$ -18.90M
Investing Cash Flow
$ -41.76M$ -87.18M$ -199.00K$ -55.00K$ -917.00K$ -96.00K
Financing Cash Flow
$ 3.53M$ 6.90M$ 190.73M$ 53.16M$ 408.51M$ 8.61M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 224.13M$ 70.97M$ 210.52M$ 60.06M$ 386.92M$ 10.53M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
-----$ 36.00K
Issuance Of Capital Stock
----$ 411.63M$ 0.00
Issuance Of Debt
--$ -8.68M$ -1.82M$ 0.00$ 10.00M
Repayment Of Debt
--$ -8.68M$ -1.82M$ -700.00K$ -1.41M
Free Cash Flow
$ -44.23M$ -59.44M$ -40.28M$ -17.62M$ -32.11M$ -18.99M
Domestic Sales
------
Foreign Sales
------
Currency in USD

ARS Pharmaceuticals Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis